PJT Partners: Three Days to the Print

PJT Partners heads into its October 27 Q3 earnings release with short sellers trimming positions, analysts cutting targets, and retail attention running at its highest level in months.

The positioning picture is notably relaxed for a stock with 7.2% of free float sold short. Short interest has fallen roughly 2.2% over the past week and is down nearly 9% from its late-September peak, when it briefly approached 1.96 million shares. Borrow conditions are loose: availability runs at 733%, meaning there are more than seven shares available to lend for every one already borrowed, well above the 52-week tightest reading of 192%. Cost to borrow has ticked up about 12% over the week but remains trivial at 0.43%, the kind of level that imposes no meaningful friction on new short positions. Options traders are equally unbothered. The put/call ratio of 0.70 is fractionally below its 20-day average of 0.71 and carries a z-score close to zero, a near-neutral read that implies no unusual hedging demand despite the imminent print. The short score of 48.4 sits in the middle of its range and has drifted slightly lower all week. Taken together, positioning looks calm rather than charged.

The Street is less sanguine. The recent direction of analyst revisions has been consistently downward. Goldman Sachs held its Buy rating but cut its target from $203 to $182 in early October. Keefe, Bruyette & Woods went further, downgrading to Market Perform and trimming from $195 to $159. UBS stayed at Neutral and lowered from $176 to $165. The consensus mean price target now sits at $161, against a stock trading at $140.94, which leaves about 14% implied upside on paper, but the downward drift in targets matters more than the level. Factor scores add nuance: the earnings surprise percentile ranks at 73, suggesting the firm has historically beaten consensus, while EPS momentum over 30 days ranks in just the 11th percentile, the weakest near-term revisions pressure in the cohort. Bulls lean on the record mandate count and Park Hill's traction in Private Equity and Private Capital Solutions. Bears flag over-reliance on restructuring revenue and what one analyst characterised as a "lackluster visible pipeline" at a valuation that leaves limited room for disappointment.

One data point worth flagging before the print is the retail attention signal. Wikipedia page views for PJT are running at a z-score of 2.7 against the company's own 90-day history, the highest reading in that window. This is an attention measure, not a revenue indicator, but the spike in traffic ahead of a quarterly print often reflects retail positioning rather than informed flow.

Insider activity over the past 90 days has been net negative: directors sold roughly $2.1 million of stock in aggregate, most prominently in an August cluster when two board members sold a combined $1.36 million at prices around $173 to $175. None of these trades were filed under a 10b5-1 plan. The stock has since pulled back roughly 19% from those sale prices, making the timing look informed in hindsight, though the sellers were directors rather than executives with direct line of sight on operating performance.

The last quarterly print, in late July, saw the stock fall 2.2% on the day before recovering to a 1.4% gain over the following five sessions. That is a modest reaction by boutique advisory standards. Close peers closed mostly lower on the week: EVR fell 0.9%, JEF dropped 1.9%, and SF shed 1.7%, while BX stood out with a 10.7% weekly gain, suggesting the alternative asset manager end of the group is in a different gear from the pure advisory boutiques. What to watch on October 27 is whether Park Hill revenues and the mandate pipeline justify the premium the stock still commands relative to where analysts have anchored their revised targets.